The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
No Access

The dexamethasone suppression test in residual schizophrenia with depression

Published Online:https://doi.org/10.1176/ajp.141.2.250

The authors administered the Carroll rating scale for depression to 100 patients with residual schizophrenia and found that 41 were also depressed. Of these 41 patients, 23 were given a dexamethasone suppression test; 7 (31%) failed to suppress cortisol. A matched control group, i.e., 23 patients with residual schizophrenia but without depression, suppressed cortisol normally after taking dexamethasone. The authors found no clinical differences between depressed patients with normal DST results and depressed patients with abnormal DST results.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.